Skip to main content
Erschienen in: Current Breast Cancer Reports 3/2013

01.09.2013 | Risk, Prevention, and Screening (DL Hershman, Section Editor)

Omega-3 Fatty Acids for Prevention of Breast Cancer: an Update and the State of the Science

verfasst von: Neil M. Iyengar, Clifford A. Hudis, Ayca Gucalp

Erschienen in: Current Breast Cancer Reports | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The quantity and makeup of dietary fat intake are known to affect human health. A variety of purported health benefits, including cancer prevention, have focused increased attention on use of omega-3 (ω-3) polyunsaturated fatty acid (PUFA) supplements. Preclinical evidence has been encouraging, and recent studies have increased our understanding of mechanisms by means of which ω-3 PUFAs may protect against breast cancer. However, epidemiological studies have yielded mixed results. Recent population studies have attempted to determine factors, for example total fat intake and the ratio of ω-3 to ω-6 PUFA intake, that may affect the action of ω-3 PUFAs. Several clinical trials, some currently ongoing, are investigating strategies to favorably alter endogenous fatty acid profiles in an attempt to develop clinically feasible prevention methods. Identification of well-defined subpopulations who are most likely to benefit from a targeted prevention approach will probably be crucial to this effort.
Literatur
1.
Zurück zum Zitat Berquin IM, Edwards IJ, Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett. 2008;269:363–77.PubMedCrossRef Berquin IM, Edwards IJ, Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett. 2008;269:363–77.PubMedCrossRef
2.
Zurück zum Zitat Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70:560S–9S.PubMed Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70:560S–9S.PubMed
3.
Zurück zum Zitat van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 2009;18:2569–78.PubMedCrossRef van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 2009;18:2569–78.PubMedCrossRef
4.
Zurück zum Zitat Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83:1467S–76S.PubMed Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83:1467S–76S.PubMed
5.
Zurück zum Zitat •• Jiang W, Zhu Z, McGinley JN, et al. Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary N-3 fatty acids. Cancer Res. 2012;72:3795–806. In this animal study, lower proliferation in chemically induced mammary tumors was observed for rats fed a diet with a high ω-3:ω-6 PUFA ratio than for rats fed a low ω-3:ω-6 PUFA ratio. Notably, high doses of PUFAs were fed to rats, which would not be achievable by diet alone.PubMedCrossRef •• Jiang W, Zhu Z, McGinley JN, et al. Identification of a molecular signature underlying inhibition of mammary carcinoma growth by dietary N-3 fatty acids. Cancer Res. 2012;72:3795–806. In this animal study, lower proliferation in chemically induced mammary tumors was observed for rats fed a diet with a high ω-3:ω-6 PUFA ratio than for rats fed a low ω-3:ω-6 PUFA ratio. Notably, high doses of PUFAs were fed to rats, which would not be achievable by diet alone.PubMedCrossRef
6.
Zurück zum Zitat Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids. 2009;81:187–91.PubMedCrossRef Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids. 2009;81:187–91.PubMedCrossRef
7.
Zurück zum Zitat Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79:935–45.PubMed Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79:935–45.PubMed
8.
Zurück zum Zitat MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295:403–15.PubMedCrossRef MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA. 2006;295:403–15.PubMedCrossRef
9.
Zurück zum Zitat Terry PD, Rohan TE, Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr. 2003;77:532–43.PubMed Terry PD, Rohan TE, Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr. 2003;77:532–43.PubMed
10.
Zurück zum Zitat Terry PD, Terry JB, Rohan TE. Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research. J Nutr. 2004;134:3412S–20S.PubMed Terry PD, Terry JB, Rohan TE. Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research. J Nutr. 2004;134:3412S–20S.PubMed
11.
Zurück zum Zitat Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332:752–60.PubMedCrossRef Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006;332:752–60.PubMedCrossRef
12.
Zurück zum Zitat Bougnoux P, Maillard V, Chajes V. Omega-6/omega-3 polyunsaturated fatty acids ratio and breast cancer. World Rev Nutr Diet. 2005;94:158–65.PubMedCrossRef Bougnoux P, Maillard V, Chajes V. Omega-6/omega-3 polyunsaturated fatty acids ratio and breast cancer. World Rev Nutr Diet. 2005;94:158–65.PubMedCrossRef
13.
Zurück zum Zitat •• Brasky TM, Lampe JW, Potter JD, et al. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev. 2010;19:1696–708. This prospective cohort study followed over 35,000 postmenopausal women. Current, but not past, use of fish oil supplements was associated with a reduced risk of developing invasive ductal carcinomas within the breast.PubMedCrossRef •• Brasky TM, Lampe JW, Potter JD, et al. Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol Biomarkers Prev. 2010;19:1696–708. This prospective cohort study followed over 35,000 postmenopausal women. Current, but not past, use of fish oil supplements was associated with a reduced risk of developing invasive ductal carcinomas within the breast.PubMedCrossRef
14.
Zurück zum Zitat Kim J, Lim SY, Shin A, et al. Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case–control study. BMC Cancer. 2009;9:216.PubMedCrossRef Kim J, Lim SY, Shin A, et al. Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case–control study. BMC Cancer. 2009;9:216.PubMedCrossRef
15.
Zurück zum Zitat Witt PM, Christensen JH, Schmidt EB, et al. Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: a case–cohort study from Denmark. Cancer Causes Control. 2009;20:1715–21.PubMedCrossRef Witt PM, Christensen JH, Schmidt EB, et al. Marine n-3 polyunsaturated fatty acids in adipose tissue and breast cancer risk: a case–cohort study from Denmark. Cancer Causes Control. 2009;20:1715–21.PubMedCrossRef
16.
Zurück zum Zitat Stripp C, Overvad K, Christensen J, et al. Fish intake is positively associated with breast cancer incidence rate. J Nutr. 2003;133:3664–9.PubMed Stripp C, Overvad K, Christensen J, et al. Fish intake is positively associated with breast cancer incidence rate. J Nutr. 2003;133:3664–9.PubMed
17.
Zurück zum Zitat Thiebaut AC, Chajes V, Gerber M, et al. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer. 2009;124:924–31.PubMedCrossRef Thiebaut AC, Chajes V, Gerber M, et al. Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer. 2009;124:924–31.PubMedCrossRef
18.
Zurück zum Zitat •• Murff HJ, Shu XO, Li H, et al. Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study. Int J Cancer. 2011;128:1434–41. This is the Shanghai Women’s Study in which over 72,000 healthy women were followed prospectively. Although the amount of any individual PUFA intake was not associated with breast cancer risk, low ω-3 PUFA intake by women who had the highest ω-6 PUFA intake was associated with elevated breast cancer risk.PubMedCrossRef •• Murff HJ, Shu XO, Li H, et al. Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study. Int J Cancer. 2011;128:1434–41. This is the Shanghai Womens Study in which over 72,000 healthy women were followed prospectively. Although the amount of any individual PUFA intake was not associated with breast cancer risk, low ω-3 PUFA intake by women who had the highest ω-6 PUFA intake was associated with elevated breast cancer risk.PubMedCrossRef
19.
Zurück zum Zitat •• Chajes V, Torres-Mejia G, Biessy C, et al. omega-3 and omega-6 Polyunsaturated fatty acid intakes and the risk of breast cancer in Mexican women: impact of obesity status. Cancer Epidemiol Biomarkers Prev. 2012;21:319–26. This is a case–control study of Mexican women with and without breast cancer. Higher levels of ω-3 PUFA intake by obese women, but not by lean or overweight women, were protective against breast cancer.PubMedCrossRef •• Chajes V, Torres-Mejia G, Biessy C, et al. omega-3 and omega-6 Polyunsaturated fatty acid intakes and the risk of breast cancer in Mexican women: impact of obesity status. Cancer Epidemiol Biomarkers Prev. 2012;21:319–26. This is a casecontrol study of Mexican women with and without breast cancer. Higher levels of ω-3 PUFA intake by obese women, but not by lean or overweight women, were protective against breast cancer.PubMedCrossRef
20.
Zurück zum Zitat Erickson KL, Hubbard NE. Fatty acids and breast cancer: the role of stem cells. Prostaglandins Leukot Essent Fatty Acids. 2010;82:237–41.PubMedCrossRef Erickson KL, Hubbard NE. Fatty acids and breast cancer: the role of stem cells. Prostaglandins Leukot Essent Fatty Acids. 2010;82:237–41.PubMedCrossRef
21.
Zurück zum Zitat Pauwels EK, Kairemo K. Fatty acid facts, part II: role in the prevention of carcinogenesis, or, more fish on the dish? Drug News Perspect. 2008;21:504–10.PubMedCrossRef Pauwels EK, Kairemo K. Fatty acid facts, part II: role in the prevention of carcinogenesis, or, more fish on the dish? Drug News Perspect. 2008;21:504–10.PubMedCrossRef
22.
Zurück zum Zitat Tapiero H, Ba GN, Couvreur P, Tew KD. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother. 2002;56:215–22.PubMedCrossRef Tapiero H, Ba GN, Couvreur P, Tew KD. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed Pharmacother. 2002;56:215–22.PubMedCrossRef
23.
Zurück zum Zitat Kaur B, Jorgensen A, Duttaroy AK. Fatty acid uptake by breast cancer cells (MDA-MB-231): effects of insulin, leptin, adiponectin, and TNFalpha. Prostaglandins Leukot Essent Fatty Acids. 2009;80:93–9.PubMedCrossRef Kaur B, Jorgensen A, Duttaroy AK. Fatty acid uptake by breast cancer cells (MDA-MB-231): effects of insulin, leptin, adiponectin, and TNFalpha. Prostaglandins Leukot Essent Fatty Acids. 2009;80:93–9.PubMedCrossRef
24.
Zurück zum Zitat • Corsetto PA, Montorfano G, Zava S, et al. Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids Health Dis. 2011;10:73. Treatment of human breast cancer cell lines in vitro with EPA or DHA induced apoptosis and reduced cell viability in this study.PubMedCrossRef • Corsetto PA, Montorfano G, Zava S, et al. Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids Health Dis. 2011;10:73. Treatment of human breast cancer cell lines in vitro with EPA or DHA induced apoptosis and reduced cell viability in this study.PubMedCrossRef
25.
Zurück zum Zitat • Blanckaert V, Ulmann L, Mimouni V, et al. Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int J Oncol. 2010;36:737–42. In this preclinical study, DHA activated the caspase cascade, thereby inducing apoptosis, in ER-negative human breast cancer cells.PubMedCrossRef • Blanckaert V, Ulmann L, Mimouni V, et al. Docosahexaenoic acid intake decreases proliferation, increases apoptosis and decreases the invasive potential of the human breast carcinoma cell line MDA-MB-231. Int J Oncol. 2010;36:737–42. In this preclinical study, DHA activated the caspase cascade, thereby inducing apoptosis, in ER-negative human breast cancer cells.PubMedCrossRef
26.
Zurück zum Zitat • Kang KS, Wang P, Yamabe N, et al. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One. 2010;5:e10296. This study demonstrated that DHA induces apoptosis in breast cancer cells in vitro by increasing intracellular ROS accumulation.PubMedCrossRef • Kang KS, Wang P, Yamabe N, et al. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One. 2010;5:e10296. This study demonstrated that DHA induces apoptosis in breast cancer cells in vitro by increasing intracellular ROS accumulation.PubMedCrossRef
27.
Zurück zum Zitat Kramer F, Johnson IT, Doleman JF, Lund EK. A comparison of the effects of soya isoflavonoids and fish oil on cell proliferation, apoptosis and the expression of oestrogen receptors alpha and beta in the mammary gland and colon of the rat. Br J Nutr. 2009;102:29–36.PubMedCrossRef Kramer F, Johnson IT, Doleman JF, Lund EK. A comparison of the effects of soya isoflavonoids and fish oil on cell proliferation, apoptosis and the expression of oestrogen receptors alpha and beta in the mammary gland and colon of the rat. Br J Nutr. 2009;102:29–36.PubMedCrossRef
28.
Zurück zum Zitat • Manni A, Xu H, Washington S, et al. The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. Cancer Prev Res (Phila). 2010;3:322–30. In this rat model of chemically induced mammary tumors, the combination of an ω-3 PUFA-rich diet and tamoxifen had a greater antitumor effect than either intervention alone.CrossRef • Manni A, Xu H, Washington S, et al. The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. Cancer Prev Res (Phila). 2010;3:322–30. In this rat model of chemically induced mammary tumors, the combination of an ω-3 PUFA-rich diet and tamoxifen had a greater antitumor effect than either intervention alone.CrossRef
29.
Zurück zum Zitat Manni A, Xu H, Washington S, et al. The effects of Tamoxifen and fish oil on mammary carcinogenesis in polyoma middle T transgenic mice. Horm Cancer. 2011;2:249–59.PubMedCrossRef Manni A, Xu H, Washington S, et al. The effects of Tamoxifen and fish oil on mammary carcinogenesis in polyoma middle T transgenic mice. Horm Cancer. 2011;2:249–59.PubMedCrossRef
30.
Zurück zum Zitat Manni A, Richie Jr JP, Xu H, et al. Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. Int J Oncol. 2011;39:1153–64.PubMed Manni A, Richie Jr JP, Xu H, et al. Effects of fish oil and Tamoxifen on preneoplastic lesion development and biomarkers of oxidative stress in the early stages of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. Int J Oncol. 2011;39:1153–64.PubMed
31.
Zurück zum Zitat Su HM, Hsieh PH, Chen HF. A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring. J Nutr Biochem. 2010;21:1033–7.PubMedCrossRef Su HM, Hsieh PH, Chen HF. A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring. J Nutr Biochem. 2010;21:1033–7.PubMedCrossRef
32.
Zurück zum Zitat Ouyang P, Jiang Y, Doan HM, et al. Weight Loss via exercise with controlled dietary intake may affect phospholipid profile for cancer prevention in murine skin tissues. Cancer Prev Res (Phila). 2010;3:466–77.CrossRef Ouyang P, Jiang Y, Doan HM, et al. Weight Loss via exercise with controlled dietary intake may affect phospholipid profile for cancer prevention in murine skin tissues. Cancer Prev Res (Phila). 2010;3:466–77.CrossRef
33.
Zurück zum Zitat Yee LD, Lester JL, Cole RM, et al. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr. 2010;91:1185–94.PubMedCrossRef Yee LD, Lester JL, Cole RM, et al. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr. 2010;91:1185–94.PubMedCrossRef
34.
Zurück zum Zitat • Djuric Z, Ren J, Brown PR, et al. Lifestyle factors associated with serum N-3 fatty acid levels in breast cancer patients. Breast. 2012;21:608–11. In this pilot study (n = 40) of women with localized breast cancer receiving chemotherapy, diet and exercise counseling were associated with an increase in blood ω-3 PUFA levels.PubMedCrossRef • Djuric Z, Ren J, Brown PR, et al. Lifestyle factors associated with serum N-3 fatty acid levels in breast cancer patients. Breast. 2012;21:608–11. In this pilot study (n = 40) of women with localized breast cancer receiving chemotherapy, diet and exercise counseling were associated with an increase in blood ω-3 PUFA levels.PubMedCrossRef
35.
Zurück zum Zitat Shannon J, King IB, Lampe JW, et al. Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China. Am J Clin Nutr. 2009;89:265–76.PubMedCrossRef Shannon J, King IB, Lampe JW, et al. Erythrocyte fatty acids and risk of proliferative and nonproliferative fibrocystic disease in women in Shanghai, China. Am J Clin Nutr. 2009;89:265–76.PubMedCrossRef
36.
Zurück zum Zitat Chajes V, Joulin V, Clavel-Chapelon F. The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk. Curr Opin Lipidol. 2011;22:6–10.PubMedCrossRef Chajes V, Joulin V, Clavel-Chapelon F. The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk. Curr Opin Lipidol. 2011;22:6–10.PubMedCrossRef
37.
Zurück zum Zitat Touvier M, Kesse-Guyot E, Andreeva VA, et al. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case–control study. Am J Clin Nutr. 2012;95:944–50.PubMedCrossRef Touvier M, Kesse-Guyot E, Andreeva VA, et al. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 PUFA intake: a nested case–control study. Am J Clin Nutr. 2012;95:944–50.PubMedCrossRef
38.
Zurück zum Zitat O’Hanlon DM, Fitzsimons H, Lynch J, et al. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer. 2002;38:2252–7.PubMedCrossRef O’Hanlon DM, Fitzsimons H, Lynch J, et al. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer. 2002;38:2252–7.PubMedCrossRef
39.
Zurück zum Zitat Basoglu M, Atamanalp SS, Yildirgan MI, et al. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res. 2007;39:136–40.PubMedCrossRef Basoglu M, Atamanalp SS, Yildirgan MI, et al. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res. 2007;39:136–40.PubMedCrossRef
40.
Zurück zum Zitat •• Signori C, DuBrock C, Richie JP, et al. Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial. Eur J Clin Nutr. 2012;66:878–84. In this interim report of an ongoing trial of raloxifene and the ω-3 PUFA supplement, Lovaza, the combination of raloxifene and Lovaza was feasible and well tolerated. The awaited primary endpoint in this trial is reduction in breast tissue density.PubMedCrossRef •• Signori C, DuBrock C, Richie JP, et al. Administration of omega-3 fatty acids and Raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial. Eur J Clin Nutr. 2012;66:878–84. In this interim report of an ongoing trial of raloxifene and the ω-3 PUFA supplement, Lovaza, the combination of raloxifene and Lovaza was feasible and well tolerated. The awaited primary endpoint in this trial is reduction in breast tissue density.PubMedCrossRef
41.
Zurück zum Zitat Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology. 2009;150:2537–42.PubMedCrossRef Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology. 2009;150:2537–42.PubMedCrossRef
42.
Zurück zum Zitat Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219–46.PubMedCrossRef Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219–46.PubMedCrossRef
43.
Zurück zum Zitat Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8:887–99.PubMedCrossRef Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8:887–99.PubMedCrossRef
44.
Zurück zum Zitat Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer. 2003;88:1721–6.PubMedCrossRef Bachelot T, Ray-Coquard I, Menetrier-Caux C, et al. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer. 2003;88:1721–6.PubMedCrossRef
45.
Zurück zum Zitat Morris PG, Hudis CA. Giri D, et al: Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila). 2011;4:1021–9.CrossRef Morris PG, Hudis CA. Giri D, et al: Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res (Phila). 2011;4:1021–9.CrossRef
46.
Zurück zum Zitat Subbaramaiah K, Howe LR, Bhardwaj P, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila). 2011;4:329–46.CrossRef Subbaramaiah K, Howe LR, Bhardwaj P, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res (Phila). 2011;4:329–46.CrossRef
47.
Zurück zum Zitat Subbaramaiah K, Morris PG, Zhou XK, et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov. 2012;2:356–65.PubMedCrossRef Subbaramaiah K, Morris PG, Zhou XK, et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov. 2012;2:356–65.PubMedCrossRef
Metadaten
Titel
Omega-3 Fatty Acids for Prevention of Breast Cancer: an Update and the State of the Science
verfasst von
Neil M. Iyengar
Clifford A. Hudis
Ayca Gucalp
Publikationsdatum
01.09.2013
Verlag
Springer US
Erschienen in
Current Breast Cancer Reports / Ausgabe 3/2013
Print ISSN: 1943-4588
Elektronische ISSN: 1943-4596
DOI
https://doi.org/10.1007/s12609-013-0112-1

Weitere Artikel der Ausgabe 3/2013

Current Breast Cancer Reports 3/2013 Zur Ausgabe

Risk, Prevention, and Screening (DL Hershman, Section Editor)

Breast Surveillance of Patients with BRCA1 and BRCA2 Mutations

Risk, Prevention, and Screening (DL Hershman, Section Editor)

Familial Breast Cancer Risk

Risk, Prevention, and Screening (DL Hershman, Section Editor)

Statins and Breast Cancer: Future Directions in Chemoprevention

Risk, Prevention, and Screening (DL Hershman, Section Editor)

Biomarker Endpoints for Early-Phase Cancer-Prevention Studies

Risk, Prevention, and Screening (DL Hershman, Section Editor)

Weight Loss Intervention for Breast Cancer Survivors: A Systematic Review

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.